Early Phase Clinical Trials
Helping our clients navigate their Phase I-IB studies
PPD’s early development services keeps an eye toward supporting your later-phase programs.
Phase I and IB trials represent the first practical tests of your compound’s clinical relevance and commercial viability. They are the culmination of years or even decades of research. Moreover, they set the stage for subsequent studies that will ultimately determine your compound’s efficacy, safety and positive impact on patient’s lives.
Maximizing success in early phase development requires a highly coordinated effort to anticipate potential challenges, recruit the right patients, engage top investigators and design a trial that will build a platform for later-stage success.
PPD’s dedicated team of global experts in early development and clinical pharmacology perform a critical assessment of your compound’s unique attributes to identify areas of strength and potential weakness that could impact the outcome of your trial and subsequent trials. Next, the team develops an integrated, early-phase program that leverages our facilities, site network, operational expertise and development experience to execute your trial in patients and/or healthy volunteers. Each step of the process is conducted with an eye toward supporting later-phase programs and regulatory submissions.
Phase I studies conducted in the past five years.
Households in our patient database.
PPD’s Early Development and Clinical Pharmacology Solutions
Our streamlined services help establish proof-of-concept by reducing time and cost from your development timeline.
PPD’s early development services provide:
Learn more about our Phase I capabilities
EARLY DEVELOPMENT GLOBAL CAPABILITIES
With over 100 studies awarded through our global network in the past five years, our areas of expertise include: renal impairment, hepatic impairment, Japanese Bridging, Chinese Bridging in China and NHV studies.
Early Development Services: ADME Study Capabilities
PPD’s early development services can perform absorption, distribution, metabolism and excretion (ADME) studies to understand how a drug is processed in the human body to assess safety and efficacy.
